Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Certain biological actions of phorbol esters cannot be duplicated by diacylglycerol (DAG). Thus, the human
neuroblastoma
cell line SH-SY5Y differentiates when exposed to 12-tetradecanoyl-13-acetyl-beta-phorbol (TPA) and protein kinase C (PKC) inhibitors, but not when exposed to DAG. To investigate the specific features of the phorbol diester molecule that might be responsible for these effects, we examined the extension of neurites, expression of neuron-specific enolase, and appearance and localization of phosphorylated high molecular weight neurofilament subunits (
NF-H
). TPA, 12-deoxy-13-tetradecanoyl-beta-phorbol, and staurosporine, but not DAG or 4-O-methyl-TPA, caused neurite outgrowth. Neuron-specific enolase was expressed in cells treated with TPA and 12-deoxy-13-tetradecanoyl-beta-phorbol but not with DAG, staurosporine, or 4-O-methyl-TPA.
NF-H
increased in the perikarya of cells treated with DAG and 4-O-methyl-TPA, in processes and to varying degrees in perikarya of TPA- and 12-deoxy-13-tetradecanoyl-beta-phorbol-treated cells, but much more in the processes than in the perikarya of staurosporine-differentiated cells. These findings and additional differences between the differentiation induced by TPA (a PKC activator) and staurosporine (a PKC inhibitor), including distinct morphology of the cell body and processes and time of appearance of the morphological phenotype, suggest that activators and inhibitors of PKC induce differentiation of SH-SY5Y cells by different mechanisms, and that the five-membered/seven-membered terpene ring region present in TPA must be intact for the induction of morphological differentiation.
...
PMID:Distinct mechanisms of differentiation of SH-SY5Y neuroblastoma cells by protein kinase C activators and inhibitors. 154 59
NEURO-2A
neuroblastoma
cells were differentiated by the addition of dibutyryl-cyclic AMP, resulting in an increase in transcription of mRNA coding for the two neurofilament polypeptides NF-L and NF-M. The mRNAs for these two polypeptides appeared to be co-expressed with both being switched on at 24 h after the addition of drug. This was in contrast to
NF-H
whose induction was only seen at 60 h following addition of drug. These results are in good agreement with the expression time course previously reported in-vivo and suggest that the neurofilament triplet polypeptides can be divided into two subsets which appear to be under different genetic control mechanisms according to their time course of expression.
...
PMID:Temporal expression of neurofilament polypeptides in differentiating neuroblastoma cells. 166 92
Neuroblastoma
cells are frequently used as targets in studies of autoimmune diseases of the nervous system. We examined the human
neuroblastoma
cell line, LAN-5, for the presence of autoantigens that react with naturally occurring autoantibodies in human sera. Antibodies to the HNK-1 and Gal(beta 1-3)GalNAc epitopes, which have been implicated in human autoimmune neuropathy and motor neuron disease, respectively, immunostained the surface of the
neuroblastoma
cells, and antibodies to the 200 kDa high molecular weight neurofilament protein (
NFH
) immunostained the cytoplasm and cell processes. The NHK-1 and Gal(beta 1-3)GalNAc epitopes were associated with several glycoprotein bands in Western blots of the
neuroblastoma
cells, and the HNK-1 epitope was also shared by a glycolipid which co-migrated with 3-sulfoglucuronyl paragloboside (SGPG) from peripheral nerve, indicating that SGPG is synthesized in neuronal cells. Northern blot analysis revealed a single RNA band of 4800 bp for
NFH
in normal brain but two RNA species of 4800 and 3800 bp in both
neuroblastoma
and adrenal cells, confirming their common origin. The
neuroblastoma
cells appear to contain antigens that bind to naturally occurring autoantibodies in human serum and might therefore be useful for detecting and investigating the effects of anti-neuronal antibodies. The antibody populations being investigated, however, should be distinguished from other autoantibodies which might be present in the patients' serum.
...
PMID:Autoantigens in human neuroblastoma cells. 168 43
Increased titres of anti-neurofilament antibodies have been reported in neurodegenerative disorders, and it has been suggested that such antibodies might be pathogenic. We investigated the specificity of an IgA monoclonal antibody (MAb) from a patient with amyotrophic lateral sclerosis which reacted with neurofilaments and bound to the surface of
neuroblastoma
cells. In Western blots, the immunoaffinity-purified IgA bound to the 220-kD, high-molecular-weight neurofilament protein (
NFH
) and cross-reacted with several closely migrating protein bands with apparent mobility of 62-68 kD in
neuroblastoma
cells and extracts of normal human spinal cord. Following crosslinking to the surface of radiolabeled
neuroblastoma
cells, the IgA MAb immunoprecipitated a 65-kD protein, indicating that the protein was present on the cell surface and available to the antibodies for binding. Several other MAbs to
NFH
did not immunostain the surface of
neuroblastoma
cells or bind to the 65-kD protein, indicating that the protein was not a fragment of
NFH
. Thus, antibody binding to the 65-kD protein, possibly by cross-reacting with
NFH
, may have contributed to the neuronal degeneration.
...
PMID:Human monoclonal antineurofilament antibody cross-reacts with a neuronal surface protein. 192 May 32
The localization of vimentin (Vm) within the Triton-insoluble cytoskeleton was characterized during differentiation of mouse NB2a/dl
neuroblastoma
cells. Vm staining increased within neurites during the first day of differentiation, and then rapidly declined in both perikarya and neurites. By contrast, immunoreactivity against extensively phosphorylated forms of the high molecular weight neurofilament subunit (
NF-H
) was absent until the third day after differentiation. Immunoblot analyses confirmed that these alterations reflected specific changes in Vm and
NF-H
steady-state levels. Metabolic labeling demonstrated a decrease in the rate of Vm synthesis by the third day of differentiation. We conclude that changes in incorporation of intermediate filament species into the axonal cytoskeleton reflect distinct stages in neurite outgrowth and maturation; i.e., the Vm filament system may participate in initial stages of neuritogenesis during which outgrowth is most rapid, while NFPs may subsequently function in the establishment of a stabilized axonal cytoskeleton.
...
PMID:Transient increase in vimentin in axonal cytoskeletons during differentiation in NB2a/d1 cells. 220 72
In neuronal systems thus far studied, newly synthesized neurofilament subunits rapidly associate with the Triton-insoluble cytoskeleton and subsequently undergo extensive phosphorylation. However, in the present study we demonstrate by biochemical and immunological criteria that NB2a/d1
neuroblastoma
cells also contain Triton-soluble, extensively phosphorylated 200-kDa high molecular weight neurofilament subunits (
NF-H
). High-speed centrifugation (100,000 g) of the Triton-soluble fraction for 1 h sedimented some, but not all, soluble
NF-H
subunits; immunoelectron microscopic analyses of the resulting pellet indicated that a portion of the
NF-H
subunits in this fraction are assembled into (Triton-soluble) neurofilaments. When cells were pulse labeled for 15 min with [35S]methionine, radiolabel was first associated with the Triton-soluble 200-kDa
NF-H
variants. Because only extensively phosphorylated
NF-H
subunits migrate at 200 kDa, whereas hypophosphorylated subunits migrate instead at 160 kDa, these findings suggest that some newly synthesized subunits were phosphorylated before they polymerized. In pulse-chase analyses, radiolabeled 200-kDa
NF-H
migrated into the 100,000 g particulate fraction of Triton-soluble extracts before its arrival in the Triton-insoluble cytoskeleton. Undifferentiated cells, which do not possess axonal neurites and lack a significant amount of Triton-insoluble, extensively phosphorylated
NF-H
, contain a sizeable pool of Triton-soluble extensively phosphorylated
NF-H
subunits and polymers. We interpret these data to indicate that the integration of newly synthesized
NF-H
into the cytoskeleton occurs in a progression of distinct stages, and that assembly of
NF-H
into neurofilaments and integration into the Triton-insoluble cytoskeleton are not prerequisites for the incorporation of certain phosphate groups on these polypeptides.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Dynamics of phosphorylation and assembly of the high molecular weight neurofilament subunit in NB2a/d1 neuroblastoma. 221 24
A 75-year-old woman had breast carcinoma, an IgA paraprotein and autopsy-proven amyotrophic lateral sclerosis. Autopsy tissues showed immune-reactive IgA within surviving motor neurons and deposits of IgA and C3 within renal glomeruli. By indirect immunofluorescence, the patient's serum contained high-titer IgA that bound to axons and to the perikarya of nerve cells in central and peripheral nervous system. The IgA paraprotein reacted with the 200 kDa, high molecular weight subunit of neurofilament protein (
NFH
) in Western blots of purified neurofilaments. It also reacted with dephosphorylated
NFH
and with
NFH
expressed as a fusion protein in E. coli, suggesting that the autoantibody recognized a peptide epitope. The IgA crossreacted with a surface antigen of cultured human
neuroblastoma
cells but mouse monoclonal antibodies to
NFH
did not. Absorption of the patient's serum with neurofilaments eliminated IgA binding to
neuroblastoma
cells, indicating that the same antibodies bound to both determinants. The IgA paraprotein seems to be an autoantibody with specificity for neurofilament protein and a cell surface component of neuronal cells; the antibody may have been important in the pathogenesis of neuronal degeneration.
...
PMID:A monoclonal IgA in a patient with amyotrophic lateral sclerosis reacts with neurofilaments and surface antigen on neuroblastoma cells. 236 86
The high molecular weight subunit of neurofilaments (
NF-H
) in mouse NB2a/d1
neuroblastoma
cells is extensively phosphorylated and exhibits an apparent molecular weight of 200 kDa by SDS gel electrophoresis. In this study, we observed that extensively phosphorylated
NF-H
variants exist as both Triton-soluble and -insoluble forms, which display different cellular distributions. Perikarya and neurites of differentiated NB2a/d1 cells were immunostained by a polyclonal antiserum (anti-
NF-H
) that specifically recognizes the extensively phosphorylated
NF-H
forms and a monoclonal antibody (SMI-31) that recognizes phosphorylated epitopes of neurofilament proteins (NFPs). When cells were extracted with Triton X-100 to remove soluble proteins, however, only axonal neurites remained immunoreactive. Immunoblot analyses established the specificity of anti-
NF-H
and SMI-31 and demonstrated that both Triton-soluble and -insoluble
NF-H
subunits exhibit an apparent molecular weight of 200 kDa. Incorporation of radiolabeled phosphate into Triton-soluble
NF-H
following incubation of intact NB2a/d1 cells with 32P-orthophosphate confirmed that the Triton-soluble form of
NF-H
is a phosphoprotein. Most
NF-H
subunits in the Triton-soluble fraction sedimented after centrifugation at 100,000 g for 1 h, indicating that they may be present as oligomers. The implications of these data for the development of neurofibrillary pathology are discussed.
...
PMID:Soluble, phosphorylated forms of the high molecular weight neurofilament protein in perikarya of cultured neuronal cells. 246 97
We used immunoblot and immunocytochemical methodologies to characterize the appearance and intracellular localization of the high molecular weight neurofilament subunit (
NF-H
) within the Triton-insoluble cytoskeleton during the first 5 days of differentiation of mouse NB2a/d1
neuroblastoma
cells. Hypophosphorylated and partially phosphorylated forms of
NF-H
were detected in cells before and throughout differentiation. By contrast, some extensively phosphorylated forms of
NF-H
were first detected on the third day of differentiation and at least one additional 200 kDa isoform was visualized in cytoskeletons only after five days of differentiation. Extensively phosphorylated forms of
NF-H
were restricted to axonal neurites; by contrast, hypophosphorylated and partially phosphorylated forms of
NF-H
were present throughout undifferentiated and differentiated cells.
...
PMID:Appearance and localization of phosphorylated variants of the high molecular weight neurofilament protein in NB2a/d1 cytoskeletons during differentiation. 251 Sep 55
NB2a/dl
neuroblastoma
cells were exposed to aluminum chloride or aluminum lactate (0.1-1 mM) for 3 and 6 days. Additional cultures were exposed to aluminum salts as the cells were stimulated to elaborate axonal neurites by dibutyryl cyclic AMP. By phase-contrast microscopy, aluminum salts had no effect on the morphology of undifferentiated (NB2a(-] or differentiated (NB2a(+] cells, or on neuritic elaboration and maintenance. Silver straining by the Bielschowsky method, however, demonstrated argyrophilic accumulations in perikarya of many NB2a(-) and NB2a(+) cells treated with aluminum salts. At the ultrastructural level, whorls of intermediate filaments were the most prominent abnormalities in neuronal perikarya. Although phosphorylated high-molecular weight neurofilament subunits (
NF-H
) are normally detected by immunocytochemical analyses only within axonal neurites of NB2a/dl cells, aluminum salt treatment caused the detection of phosphorylated epitopes of
NF-H
within perikaryal of NB2a(-) and NB2a(+) cytoskeletons, suggesting that the argyrophilic filamentous accumulations are composed at least partly of phosphorylated
NF-H
.
...
PMID:Aluminum salts induce the accumulation of neurofilaments in perikarya of NB2a/dl neuroblastoma. 275 11
1
2
3
Next >>